Diagnosis and treatment of Zollinger-Ellison syndrome (Q39524669)

12 September 2017

1 reference

title

Diagnosis and treatment of Zollinger-Ellison syndrome (English)

1 reference

12 September 2017

Mignon M

1

1 reference

12 September 2017

Bonfils S

series ordinal

2

1 reference

12 September 2017

publication date

1 July 1988

1 reference

Bailliere's clinical gastroenterology

12 September 2017

published in

1 reference

12 September 2017

volume

2

1 reference

12 September 2017

issue

3

1 reference

12 September 2017

page(s)

677-698

1 reference

Frequency of endocrine disorders in patients with the Zollinger-Ellison syndrome

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Ectopic gastrinoma and Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Control of acute Zollinger-Ellison syndrome with intravenous omeprazole

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Cimetidine treatment of acute and chronic zollinger-ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Results of surgical management in 92 consecutive patients with Zollinger-Ellison syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Prolonged treatment of Zollinger-Ellison syndrome by long-acting somatostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Secretin provocation in normal and duodenal ulcer subjects. Is the gastrin rise in Zollinger-Ellison syndrome paradoxic or exaggeration?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

The syndrome of gastric argyrophil carcinoid tumors and nonantral gastric atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Selective venous sampling for gastrin to localize gastrinomas. A prospective assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Effectiveness of omeprazole in seven patients with Zollinger-Ellison syndrome resistant to histamine H2-receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

The Zollinger-Ellison syndrome--23 years later

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Serum gastrin response to secretin after vagotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Duodenal wall tumors and the Zollinger-Ellison syndrome. Surgical management

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Basis for failure of cimetidine in patients with Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Zollinger-Ellison Syndrome: Current Concepts and Management

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Antral gastrin cell hyperplasia in patients with peptic ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Comparative study of the value of the calcium, secretin, and meal stimulated increase in serum gastrin to the diagnosis of the Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Prevalence of endocrine abnormalities in patients with the Zollinger-Ellison syndrome and in their families

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Role of selective angiography in the management of patients with Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Interest of a combined antisecretory treatment, cimetidine and pirenzepin, in the management of severe forms of Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Gynecomastia and histamine-2 antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

A comparative evaluation of secretin bolus and secretin infusion as secretin provocation tests in the Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Current approach to the management of tumoral process in patients with gastrinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Development of gastric argyrophil carcinoid tumors in a case of Zollinger-Ellison syndrome with primary hyperparathyroidism during long-term antisecretory treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Streptozocin Alone Compared with Streptozocin plus Fluorouracil in the Treatment of Advanced Islet-Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Excisional therapy for ulcerogenic tumors of the duodenum: long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Treatment of Zollinger-Ellison syndrome with exploratory laparotomy, proximal gastric vagotomy, and H2-receptor antagonists. A prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Abnormal pancreatic polypeptide release by secretin infusion in Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

The gastrinoma triangle: operative implications

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Benign and malignant gastrinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

12 The Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Treatment of Zollinger–Ellison Syndrome with Streptozotocin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

The role of surgery in the Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Evaluation of antisecretory drug therapy of zollinger-ellison syndrome (ZES) using 24-hour pH monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Prospective study of the ability of computed axial tomography to localize gastrinomas in patients with Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

ENDOCRINE ADENOMATOSIS AND PEPTIC ULCER IN A LARGE KINDRED. INHERITED MULTIPLE TUMORS AND MOSAIC PLEIOTROPISM IN MAN

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue symptomatic and peptide responses

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

Thirty years' experience with gastrinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2888%2980013-7

7 January 2021

10.1016/S0950-3528(88)80013-7

Identifiers

DOI

1 reference

12 September 2017

1 reference